Impact of SARS-CoV-2 heat inactivation on active protease biomarkers in sputum sol

C. Mcgranaghan (Belfast (Belfast), United Kingdom), P. Weir (Belfast (Belfast), United Kingdom), D. Mccafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom)

Source: Virtual Congress 2021 – Back to infection basics
Session: Back to infection basics
Session type: E-poster
Number: 2361

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Mcgranaghan (Belfast (Belfast), United Kingdom), P. Weir (Belfast (Belfast), United Kingdom), D. Mccafferty (Belfast (Belfast), United Kingdom), K. Moffitt (Belfast (Belfast), United Kingdom), T. Ferguson (Belfast (Belfast), United Kingdom). Impact of SARS-CoV-2 heat inactivation on active protease biomarkers in sputum sol. 2361

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased detection of interleukin-;5 in sputum by addition of protease inhibitors
Source: Eur Respir J 2001; 18: 685-691
Year: 2001



Development of the first protease multiplex immunoassay for active neutrophilic serine protease biomarkers
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Investigating optimal sputum processing methods for active neutrophil elastase quantification
Source: International Congress 2017 – Techniques in biomarker selection
Year: 2017



Macrophage chromatin condition and protease inhibitor activity studying in brush-biopsies at patients with infectious COPD exacerbation
Source: Eur Respir J 2007; 30: Suppl. 51, 142s
Year: 2007

Relationship between serum and sol secretory leukoprotease inhibitor (SLPI) during exacerbations of chronic bronchitis
Source: Eur Respir J 2006; 28: Suppl. 50, 796s
Year: 2006

Increased serum concentration of urinary trypsin inhibitor with asthma exacerbation
Source: Eur Respir J 2003; 22: 739-742
Year: 2003



SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011



Validation of sputum supernatant biomarker assays in stable and exacerbating COPD subjects
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019

Heat shock proteins and FKBP51 expression in sputum cells of COPD patients during formoterol/budesonide/theophylline therapy
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010


Detection and inhibition of ENaC-activating proteases associated with airway dehydration in COPD
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017

Proteolytic activity of sputum and serum in patients with COPD exacerbation in dependence on smoking
Source: Eur Respir J 2003; 22: Suppl. 45, 416s
Year: 2003

LSC Abstract – A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015

LSC - 2019 - Sputum protein profiling identifies a key role for neutrophil extracellular traps in exacerbations of bronchiectasis and treatment response
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019

A functional variant of secretory leukocyte protease inhibitor (SLPI) with improved anti-inflammatory activity against pulmonary infection
Source: Lung Science Conference 2015
Year: 2015

The impact of silver ions on decrease in sputum viscosity among the patients with asthma
Source: Virtual Congress 2020 – Comprehensive care and pulmonary rehabilitation for chronic respiratory diseases
Year: 2020


Mycobacterial heat shock protein 16 kDa, marker of dormant stage of mycobacteria, in precipitated circulating immune complexes in sarcoidosis
Source: Annual Congress 2011 - Biomarkers in sarcoidosis
Year: 2011

The adaptation of a point of care test for the quantitative determination of active neutrophil elastase in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020


Effect of saliva contamination on induced sputum cell counts, IL-8 and eosinophil cationic protein levels
Source: Eur Respir J 2004; 23: 759-762
Year: 2004



Can we protect airways against heat shock? A quasi-real time assay of protein kinase function in biopsies from volunteers showing a differential thermo-protective role for PKC and PKA
Source: Eur Respir J 2002; 20: Suppl. 38, 480s
Year: 2002

Validation of an activity-based immunoassay for measurement of active cathepsin g in sputum
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020